Exozymes Inc (EXOZ) insider trading
Every open-market stock purchase and sale by Exozymes Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Michael Heltzen (CEO) bought $6.4K in the last 90 days.
Last 12 months: insiders bought $6.4K (1 buy) and sold $15.4K (1 sale). Last close $3.90 on Oct 22, 2026.
Recent EXOZ insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 1, 2026 | Christopher A Marlett (10% owner) | Bought (not open market) | — |
| Oct 1, 2026 | James Joseph Lalonde (Director) | Bought (not open market) | — |
| Oct 1, 2026 | Edgardo Javier Rayo (Director) | Bought (not open market) | — |
| Oct 1, 2026 | Anthony Digiandomenico (10% owner) | Bought (not open market) | — |
| Oct 1, 2026 | James Ulrich Bowie (Director) | Bought (not open market) | — |
| Oct 1, 2026 | Lon E Bell (Director) | Bought (not open market) | — |
| Sep 14, 2026 | Fouad Nawaz (President) | Bought (not open market) | — |
| Aug 26, 2026 | Michael Heltzen (CEO) | Bought | $1.9K |
| Aug 26, 2026 | Michael Heltzen (CEO) | Bought | $1.8K |
| Aug 26, 2026 | Michael Heltzen (CEO) | Bought | $30 |
| Aug 25, 2026 | Michael Heltzen (CEO) | Bought | $1.9K |
| Aug 25, 2026 | Michael Heltzen (CEO) | Bought | $750 |
| Aug 19, 2026 | Michael Heltzen (CEO) | Bought (not open market) | $56.6K |
| Aug 19, 2026 | Tyler Paz Korman (C-suite exec) | Bought (not open market) | — |
| Aug 19, 2026 | Damien Alan Perriman (C-suite exec) | Bought (not open market) | — |
| Aug 19, 2026 | Damien Alan Perriman (C-suite exec) | Bought (not open market) | — |
| Aug 19, 2026 | Tyler Paz Korman (C-suite exec) | Bought (not open market) | — |
| Apr 9, 2026 | Tyler Paz Korman (C-suite exec) | Sold | $7.9K |
| Apr 8, 2026 | Tyler Paz Korman (C-suite exec) | Sold | $7.5K |
| Apr 1, 2026 | Damien Alan Perriman (C-suite exec) | Bought (not open market) | $75K |
| Apr 1, 2026 | Fouad Nawaz (President) | Bought (not open market) | $50.6K |
| Apr 1, 2026 | Tyler Paz Korman (C-suite exec) | Bought (not open market) | $45K |
| Apr 1, 2026 | Paul Hideo Opgenorth (President) | Bought (not open market) | $33.8K |
| Apr 1, 2026 | Damien Alan Perriman (C-suite exec) | Bought (not open market) | — |
| Apr 1, 2026 | Damien Alan Perriman (C-suite exec) | Bought (not open market) | — |
Who's trading EXOZ
- Edgardo Javier Rayo, Director: other filings, last Oct 1, 2026
- James Ulrich Bowie, Director: other filings, last Oct 1, 2026
- Anthony Digiandomenico, 10% owner: other filings, last Oct 1, 2026
- James Joseph Lalonde, Director: other filings, last Oct 1, 2026
- Christopher A Marlett, 10% owner: other filings, last Oct 1, 2026
- Lon E Bell, Director: other filings, last Oct 1, 2026
- Fouad Nawaz, President: other filings, last Sep 14, 2026
- Michael Heltzen, CEO: bought $6.4K (5 buys), last Aug 26, 2026
- Damien Alan Perriman, C-suite exec: other filings, last Aug 19, 2026
- Tyler Paz Korman, C-suite exec: sold $15.4K (2 sales), last Aug 19, 2026
- Paul Hideo Opgenorth, President: other filings, last Apr 1, 2026
Get free alerts when an insider at Exozymes Inc files a new trade →